CVD Articles

Articles
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability
He L, Liu M, Zhuang X, et al.
Journal:
J Am Heart Assoc

First published: January 31, 2024 DOI: 10.1161/JAHA.123.030132
View
- Share
Articles
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis
Björnson E, Adiels M, Taskinen MR, et al.
Journal:
J Am Coll Cardiol

First published: January 23, 2024 DOI: 10.1016/j.jacc.2023.10.039
View
- Share
Articles
Exposome in ischaemic heart disease: beyond traditional risk factors
Montone RA, Camilli M, Calvieri C, et al.
Journal:
Eur Heart J

First published: January 18, 2024 DOI: 10.1093/eurheartj/ehae001
View
- Share
Articles
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
Weintraub WS, Bhatt DL, Zhang Z, et al.
Journal:
J Am Heart Assoc

First published: December 29, 2023 DOI: 10.1161/JAHA.123.032413
View
- Share
Articles
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias
Tokgözoğlu L, Orringer C, Catapano AL
Journal:
Eur Heart J

First published: December 28, 2023 DOI: 10.1093/eurheartj/ehad837
View
- Share
Articles
Omega-3 fatty acids and cardiovascular prevention: is the jury still out?
Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ
Journal:
Intern Med J

First published: December 17, 2023 DOI: 10.1111/imj.16283
View
- Share
Articles
TV Viewing From Young Adulthood to Middle Age and Cardiovascular Disease Risk
Nagata JM, Vittinghoff E, Dooley EE, et al.
Journal:
Am J Prev Med

First published: December 10, 2023 DOI: 10.1016/j.amepre.2023.11.004
View
- Share
Articles
Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association
Paluch AE, Boyer WR, Franklin BA, et al.
Journal:
Circulation

First published: December 7, 2023 DOI: 10.1161/CIR.0000000000001189
View
- Share
Articles
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review
McClintick DJ, Giugliano RP
Journal:
Curr Opin Lipidol

First published: December 1, 2023 DOI: 10.1097/MOL.0000000000000897
View
- Share
Articles
Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network meta-analysis
Pamporis K, Karakasis P, Simantiris S, et al.
Journal:
Clin Investig Arterioscler

First published: November 30, 2023 DOI: 10.1016/j.arteri.2023.11.003
View
- Share
Articles
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
Corpeleijn WE, de Waal WJ, Schipper HS, et al.
Journal:
Diabetologia

First published: November 30, 2023 DOI: 10.1007/s00125-023-06041-z
View
- Share
Articles
Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia
Paquette M, Cariou B, Bernard S, et al.
Journal:
Arterioscler Thromb Vasc Biol

First published: November 30, 2023 DOI: 10.1161/ATVBAHA.123.319957
View
- Share

1 2 3 … 5

CVD Articles

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Articles

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

Björnson E, Adiels M, Taskinen MR, et al.

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Articles

Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States

Weintraub WS, Bhatt DL, Zhang Z, et al.

Articles

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgözoğlu L, Orringer C, Catapano AL

Articles

Omega-3 fatty acids and cardiovascular prevention: is the jury still out?

Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ

Articles

TV Viewing From Young Adulthood to Middle Age and Cardiovascular Disease Risk

Nagata JM, Vittinghoff E, Dooley EE, et al.

Articles

Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association

Paluch AE, Boyer WR, Franklin BA, et al.

Articles

Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review

McClintick DJ, Giugliano RP

Articles

Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network meta-analysis

Pamporis K, Karakasis P, Simantiris S, et al.

Articles

Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia

Corpeleijn WE, de Waal WJ, Schipper HS, et al.

Articles

Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia

Paquette M, Cariou B, Bernard S, et al.

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Share

Articles

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

Björnson E, Adiels M, Taskinen MR, et al.

Share

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Share

Articles

Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States

Weintraub WS, Bhatt DL, Zhang Z, et al.

Share

Articles

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgözoğlu L, Orringer C, Catapano AL

Share

Articles

Omega-3 fatty acids and cardiovascular prevention: is the jury still out?

Hamilton-Craig C, Kostner K, Colquhoun D, Nicholls SJ

Share

Articles

TV Viewing From Young Adulthood to Middle Age and Cardiovascular Disease Risk

Nagata JM, Vittinghoff E, Dooley EE, et al.

Share

Articles

Resistance Exercise Training in Individuals With and Without Cardiovascular Disease: 2023 Update: A Scientific Statement From the American Heart Association

Paluch AE, Boyer WR, Franklin BA, et al.

Share

Articles

Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review

McClintick DJ, Giugliano RP

Share

Articles

Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network meta-analysis

Pamporis K, Karakasis P, Simantiris S, et al.

Share

Articles

Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia

Corpeleijn WE, de Waal WJ, Schipper HS, et al.

Share

Articles

Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia

Paquette M, Cariou B, Bernard S, et al.

Share